Approval · Notice of Compliance 23030 · 2019
IBUPROFEN: Notice of Compliance 23030
Issued December 16, 2019
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 23030
- Date
- December 16, 2019
- Company
- JAMP Pharma CorporationBoucherville, Quebec, Canada
- Product type
- Nonprescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Labelling Only
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| IBUPROFEN | Not yet assigned | — |
Medicinal ingredients
- IBUPROFEN 400 MG per TAB